{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:25:20Z","timestamp":1790429120397,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR057230"],"award-info":[{"award-number":["P30 AR057230"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR048179"],"award-info":[{"award-number":["R01 AR048179"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL126204"],"award-info":[{"award-number":["R01 HL126204"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA 274143"],"award-info":[{"award-number":["MDA 274143"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["Venture Philanthropy Program"],"award-info":[{"award-number":["Venture Philanthropy Program"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Duchenne muscular dystrophy (DMD) is a degenerative muscle disease caused by mutations in the dystrophin gene. Loss of dystrophin prevents the formation of a critical connection between the muscle cell membrane and the extracellular matrix. Overexpression of sarcospan (SSPN) in the mouse model of DMD restores the membrane connection and reduces disease severity, making SSPN a promising therapeutic target for pharmacological upregulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using a previously described cell-based promoter reporter assay of SSPN gene expression (hSSPN-EGFP), we conducted high-throughput screening on libraries of over 200,000 curated small molecules to identify SSPN modulators. The hits were validated in both hSSPN-EGFP and hSSPN-luciferase reporter cells. Hit selection was conducted on dystrophin-deficient mouse and human myotubes with assessments of (1) SSPN gene expression using quantitative PCR and (2) SSPN protein expression using immunoblotting and an ELISA. A membrane stability assay using osmotic shock was used to validate the functional effects of treatment followed by cell surface biotinylation to label cell surface proteins. Dystrophin-deficient <jats:italic>mdx<\/jats:italic> mice were treated with compound, and muscle was subjected to quantitative PCR to assess SSPN gene expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified and validated lead compounds that increased SSPN gene and protein expression in dystrophin-deficient mouse and human muscle cells. The lead compound OT-9 increased cell membrane localization of compensatory laminin-binding adhesion complexes and improved membrane stability in DMD myotubes. We demonstrated that the membrane stabilizing benefit is dependent on SSPN. Intramuscular injection of OT-9 in the mouse model of DMD increased SSPN gene expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study identifies a pharmacological approach to treat DMD and sets the path for the development of SSPN-based therapies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13395-020-00244-3","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T07:02:42Z","timestamp":1600412562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"10","author":[{"given":"Cynthia","family":"Shu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubov","family":"Parfenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Mokhonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judd R.","family":"Collado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Damoiseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varghese","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6630-6713","authenticated-orcid":false,"given":"Rachelle H.","family":"Crosbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"issue":"1","key":"244_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, et al. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis. 2017;12(1):79.","journal-title":"Orphanet J Rare Dis"},{"key":"244_CR2","doi-asserted-by":"crossref","unstructured":"Schnell F, Donoghue C, Dworzak J, Charleston J, Frank D, Wilton S, et al. Development of a validated Western blot method for quantification of human dystrophin protein used in Phase II and III clinical trials of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD) (P5.105). Neurology. 2017;88(16 Supplement):P5.105.","DOI":"10.1016\/S0960-8966(17)30264-X"},{"issue":"9","key":"244_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0883073810371004","volume":"25","author":"RT Moxley","year":"2010","unstructured":"Moxley RT, Pandya S, Ciafaloni E, Fox DJ, Campbell K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol. 2010;25(9):1116\u201329.","journal-title":"J Child Neurol"},{"issue":"6","key":"244_CR4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987;51(6):919\u201328.","journal-title":"Cell."},{"issue":"6212","key":"244_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/338259a0","volume":"338","author":"KP Campbell","year":"1989","unstructured":"Campbell KP, Kahl SD. Association of dystrophin and an integral membrane glycoprotein. Nature. 1989;338(6212):259\u201362.","journal-title":"Nature."},{"issue":"6273","key":"244_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","volume":"345","author":"JM Ervasti","year":"1990","unstructured":"Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 1990;345(6273):315\u20139.","journal-title":"Nature."},{"issue":"3","key":"244_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0896-6273(91)90301-F","volume":"7","author":"K Ohlendieck","year":"1991","unstructured":"Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron. 1991;7(3):499\u2013508.","journal-title":"Neuron."},{"issue":"14","key":"244_CR8","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1016\/S0021-9258(18)31565-5","volume":"266","author":"JM Ervasti","year":"1991","unstructured":"Ervasti JM, Kahl SD, Campbell KP. Purification of dystrophin from skeletal muscle. J Biol Chem. 1991;266(14):9161\u20135.","journal-title":"J Biol Chem"},{"issue":"50","key":"244_CR9","doi-asserted-by":"publisher","first-page":"31221","DOI":"10.1074\/jbc.272.50.31221","volume":"272","author":"RH Crosbie","year":"1997","unstructured":"Crosbie RH, Heighway J, Venzke DP, Lee JC, Campbell KP. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem. 1997;272(50):31221\u20134.","journal-title":"J Biol Chem"},{"issue":"2","key":"244_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","volume":"1772","author":"JM Ervasti","year":"2007","unstructured":"Ervasti JM. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta. 2007;1772(2):108\u201317.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"244_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0092-8674(88)90065-7","volume":"54","author":"E Bonilla","year":"1988","unstructured":"Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, et al. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell. 1988;54(4):447\u201352.","journal-title":"Cell."},{"issue":"2","key":"244_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/00005072-199303000-00004","volume":"52","author":"G Karpati","year":"1993","unstructured":"Karpati G, Carpenter S, Morris GE, Davies KE, Guerin C, Holland P. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol. 1993;52(2):119\u201328.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"244_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s004410051279","volume":"296","author":"DJ Burkin","year":"1999","unstructured":"Burkin DJ, Kaufman SJ. The alpha7beta1 integrin in muscle development and disease. Cell Tissue Res. 1999;296(1):183\u201390.","journal-title":"Cell Tissue Res"},{"issue":"6404","key":"244_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/360588a0","volume":"360","author":"K Matsumura","year":"1992","unstructured":"Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature. 1992;360(6404):588\u201391.","journal-title":"Nature."},{"issue":"3","key":"244_CR15","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0006-291X(05)81320-8","volume":"180","author":"M Takemitsu","year":"1991","unstructured":"Takemitsu M, Ishiura S, Koga R, Kamakura K, Arahata K, Nonaka I, et al. Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx mice. Biochem Biophys Res Commun. 1991;180(3):1179\u201386.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"244_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0960-8966(92)90004-P","volume":"2","author":"TR Helliwell","year":"1992","unstructured":"Helliwell TR, Man NT, Morris GE, Davies KE. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromuscul Disord. 1992;2(3):177\u201384.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"244_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s004010050922","volume":"96","author":"S Teijeira","year":"1998","unstructured":"Teijeira S, Teijeiro A, Fern\u00e1ndez R, Navarro C. Subsarcolemmal expression of utrophin in neuromuscular disorders: an immunohistochemical study of 80 cases. Acta Neuropathol. 1998;96(5):481\u20136.","journal-title":"Acta Neuropathol"},{"issue":"26","key":"244_CR18","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1093\/hmg\/11.26.3333","volume":"11","author":"S Squire","year":"2002","unstructured":"Squire S, Raymackers JM, Vandebrouck C, Potter A, Tinsley J, Fisher R, et al. Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum Mol Genet. 2002;11(26):3333\u201344.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"244_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0002-9440(10)62249-3","volume":"166","author":"DJ Burkin","year":"2005","unstructured":"Burkin DJ, Wallace GQ, Milner DJ, Chaney EJ, Mulligan JA, Kaufman SJ. Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am J Pathol. 2005;166(1):253\u201363.","journal-title":"Am J Pathol"},{"issue":"1","key":"244_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1083\/jcb.145.1.153","volume":"145","author":"RH Crosbie","year":"1999","unstructured":"Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, et al. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol. 1999;145(1):153\u201365.","journal-title":"J Cell Biol"},{"issue":"4","key":"244_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.yexcr.2006.11.021","volume":"313","author":"G Miller","year":"2007","unstructured":"Miller G, Wang EL, Nassar KL, Peter AK, Crosbie RH. Structural and functional analysis of the sarcoglycan-sarcospan subcomplex. Exp Cell Res. 2007;313(4):639\u201351.","journal-title":"Exp Cell Res"},{"issue":"3","key":"244_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.200808027","volume":"183","author":"AK Peter","year":"2008","unstructured":"Peter AK, Marshall JL, Crosbie RH. Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex. J Cell Biol. 2008;183(3):419\u201327.","journal-title":"J Cell Biol"},{"issue":"7","key":"244_CR23","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/hmg\/ddu615","volume":"24","author":"JL Marshall","year":"2015","unstructured":"Marshall JL, Oh J, Chou E, Lee JA, Holmberg J, Burkin DJ, et al. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and \u03b17 integrin. Hum Mol Genet. 2015;24(7):2011\u201322.","journal-title":"Hum Mol Genet"},{"issue":"24","key":"244_CR24","first-page":"5395","volume":"25","author":"EM Gibbs","year":"2016","unstructured":"Gibbs EM, Marshall JL, Ma E, Nguyen TM, Hong G, Lam JS, et al. High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD. Hum Mol Genet. 2016;25(24):5395\u2013406.","journal-title":"Hum Mol Genet"},{"key":"244_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1161\/JAHA.115.002481","volume":"4","author":"MS Parvatiyar","year":"2015","unstructured":"Parvatiyar MS, Marshall JL, Nguyen RT, Jordan MC, Richardson VA, Roos KP, et al. Sarcospan regulates cardiac isoproterenol response and prevents duchenne muscular dystrophy-associated cardiomyopathy. J Am Heart Assoc. 2015;4:12.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"244_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13395-019-0218-x","volume":"9","author":"C Shu","year":"2019","unstructured":"Shu C, Kaxon-Rupp AN, Collado JR, Damoiseaux R, Crosbie RH. Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy. Skelet Muscle. 2019;9(1):32.","journal-title":"Skelet Muscle"},{"issue":"4","key":"244_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/1386207317666140323134621","volume":"17","author":"R Damoiseaux","year":"2014","unstructured":"Damoiseaux R. UCLA\u2019s molecular screening shared resource: enhancing small molecule discovery with functional genomics and new technology. Comb Chem High Throughput Screen. 2014;17(4):356\u201368.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"2","key":"244_CR28","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1006\/dbio.1994.1103","volume":"162","author":"JE Morgan","year":"1994","unstructured":"Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, Jat PS, et al. Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol. 1994;162(2):486\u201398.","journal-title":"Dev Biol"},{"key":"244_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/2044-5040-1-34","volume":"1","author":"K Mamchaoui","year":"2011","unstructured":"Mamchaoui K, Trollet C, Bigot A, Negroni E, Chaouch S, Wolff A, et al. Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders. Skelet Muscle. 2011;1:34.","journal-title":"Skelet Muscle"},{"issue":"3","key":"244_CR30","first-page":"532","volume":"15","author":"P Chomczynski","year":"1993","unstructured":"Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993;15(3):532\u20134 6-7.","journal-title":"Biotechniques."},{"issue":"7","key":"244_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25\u2009years of image analysis. Nat Methods. 2012;9(7):671\u20135.","journal-title":"Nat Methods"},{"issue":"4","key":"244_CR32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","volume":"18","author":"CS Young","year":"2016","unstructured":"Young CS, Hicks MR, Ermolova NV, Nakano H, Jan M, Younesi S, et al. A Single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell. 2016;18(4):533\u201340.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"244_CR33","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/1087057111405851","volume":"16","author":"XD Zhang","year":"2011","unstructured":"Zhang XD. Illustration of SSMD, z score, SSMD*, z* score, and t statistic for hit selection in RNAi high-throughput screens. J Biomol Screen. 2011;16(7):775\u201385.","journal-title":"J Biomol Screen"},{"issue":"7","key":"244_CR34","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1083\/jcb.201110032","volume":"197","author":"JL Marshall","year":"2012","unstructured":"Marshall JL, Holmberg J, Chou E, Ocampo AC, Oh J, Lee J, et al. Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration. J Cell Biol. 2012;197(7):1009\u201327.","journal-title":"J Cell Biol"},{"issue":"Pt 12","key":"244_CR35","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1242\/jcs.064808","volume":"123","author":"D Li","year":"2010","unstructured":"Li D, Bareja A, Judge L, Yue Y, Lai Y, Fairclough R, et al. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci. 2010;123(Pt 12):2008\u201313.","journal-title":"J Cell Sci"},{"issue":"15","key":"244_CR36","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1074\/jbc.M513121200","volume":"281","author":"IN Rybakova","year":"2006","unstructured":"Rybakova IN, Humston JL, Sonnemann KJ, Ervasti JM. Dystrophin and utrophin bind actin through distinct modes of contact. J Biol Chem. 2006;281(15):9996\u201310001.","journal-title":"J Biol Chem"},{"issue":"3","key":"244_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/21678707.2018.1438261","volume":"6","author":"S Guiraud","year":"2018","unstructured":"Guiraud S, Roblin D, Kay DE. The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy. Expert Opin Orphan D. 2018;6(3):179\u201392.","journal-title":"Expert Opin Orphan D"},{"issue":"12","key":"244_CR38","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/4033","volume":"4","author":"J Tinsley","year":"1998","unstructured":"Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med. 1998;4(12):1441\u20134.","journal-title":"Nat Med"},{"issue":"11","key":"244_CR39","doi-asserted-by":"publisher","first-page":"e123855","DOI":"10.1172\/jci.insight.123855","volume":"4","author":"MS Parvatiyar","year":"2019","unstructured":"Parvatiyar MS, Brownstein AJ, Kanashiro-Takeuchi RM, Collado JR, Dieseldorff Jones KM, Gopal J, et al. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy. JCI Insight. 2019;4(11):e123855.","journal-title":"JCI Insight"},{"issue":"13","key":"244_CR40","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/hmg\/ddz049","volume":"28","author":"S Guiraud","year":"2019","unstructured":"Guiraud S, Edwards B, Babbs A, Squire SE, Berg A, Moir L, et al. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. Hum Mol Genet. 2019;28(13):2189\u2013200.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"244_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","volume":"15","author":"IEC Verhaart","year":"2019","unstructured":"Verhaart IEC, Aartsma-Rus A. Therapeutic developments for Duchenne muscular dystrophy. Nat Rev Neurol. 2019;15(7):373\u201386.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"244_CR42","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1021\/acs.jmedchem.9b01547","volume":"63","author":"M Chatzopoulou","year":"2020","unstructured":"Chatzopoulou M, Claridge TDW, Davies KE, Davies SG, Elsey DJ, Emer E, et al. Isolation, structural identification, synthesis, and pharmacological profiling of 1,2-trans-dihydro-1,2-diol metabolites of the utrophin modulator ezutromid. J Med Chem. 2020;63(5):2547\u201356.","journal-title":"J Med Chem"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-020-00244-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T23:35:17Z","timestamp":1631921717000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-020-00244-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1186\/s13395-020-00244-3","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All protocols and procedures were performed in accordance with guidelines set by Environmental Health, and Safety at the University of California Los Angeles. All mouse experiments were performed according to the rules and regulations approved by the Institutional Animal Care and Use Committee at the University of California, Los Angeles (approval # 2000-029-61A).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}